Paper Details

Paper Title

Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.

Paper Journal Title

Int J Cancer

Paper Citation Count

Paper Publication Year

2020

Bio Mention

Mesh Descriptor

Author Name	Affiliation
Volker Endris	Institute of Pathology, University Hospital Heidelberg
Volker Endris
Anna-Lena Volckmar	Institute of Pathology, University Hospital Heidelberg
Olaf Neumann	Institute of Pathology, University Hospital Heidelberg
Martina Kirchner	Institute of Pathology, University Hospital Heidelberg
Jan Budczies	Institute of Pathology, University Hospital Heidelberg
Michael Allg??uer	Institute of Pathology, University Hospital Heidelberg
Daniel Kazdal	Institute of Pathology, University Hospital Heidelberg
Peter Schirmacher	Institute of Pathology, University Hospital Heidelberg
Albrecht Stenzinger	Institute of Pathology, University Hospital Heidelberg
Albrecht Stenzinger

1 - 11

Dataset	Description	Source Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link
OncoMine	Cancer microarray data by gene or cancer type	Link

1 - 15

Paper Details

Column Actions

Datasets